Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Inflammatory Bowel Diseases

Free Subscription 01.06.2026 1 Am J Gastroenterol 2 BMC Gastroenterol 5 Clin Gastroenterol Hepatol 8 Dig Dis Sci 2 Dis Colon Rectum 3 Eur J Gastroenterol Hepatol 1 Gastroenterol Hepatol 3 Gastroenterology 1 Gut 2 Inflamm Bowel Dis 1 J Clin Gastroenterol 3 J Crohns Colitis 1 J Gastroenterol 1 PLoS One 1 Z Gastroenterol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Gastroenterol

1. AXELRAD JE, Faye A, Siegel CA
   Communicating Risk and Safety of Inflammatory Bowel Disease Therapies.
   Am J Gastroenterol. 2026 May 27. doi: 10.14309/ajg.0000000000004068.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

2. WU YH, Li TC, Li CI, Liu CS, et al
   Epidemiology of diagnosed inflammatory bowel disease in Taiwan population from 2011 to 2021: a population-based study.
   BMC Gastroenterol. 2026 May 29. doi: 10.1186/s12876-026-04973.
   PubMed         Abstract available
   
   
3. ABU SNEINEH A, Haj Ali S, Mazzawi T, Mohtaseb MS, et al
   Prevalence of symptoms of anxiety and depression in postoperative patients with Crohn's disease: a comparative cross-sectional study.
   BMC Gastroenterol. 2026 May 26. doi: 10.1186/s12876-026-04957.
   PubMed         Abstract available
   
   

   
   Clin Gastroenterol Hepatol

4. PALOMINO L, Velasco Rodriguez-Belvis M, Casanova MJ, Leo-Carnerero E, et al
   Psychomotor Development in Infants Following Maternal Exposure to Biologics: Results From the DUMBO Registry.
   Clin Gastroenterol Hepatol. 2026;24:1688-1701.
   PubMed         Abstract available
   
   
5. YAO J, Wu H, Wu L, Yu Q, et al
   Combined Upadacitinib and Vedolizumab as 8-Week Induction Therapy for Moderate-to-Severe Ulcerative Colitis: A Multicenter, Randomized Controlled Trial.
   Clin Gastroenterol Hepatol. 2026 May 21:S1542-3565(26)00388.
   PubMed         Abstract available
   
   
6. AGUAS M, Del Hoyo J, Vicente R, Barreiro-de Acosta M, et al
   The TECCU-based telemonitoring platform for Inflammatory Bowel Disease is Cost-Effective: A Multicenter GETECCU Trial.
   Clin Gastroenterol Hepatol. 2026 May 25:S1542-3565(26)00351.
   PubMed         Abstract available
   
   
7. LEIBOVITZH H, Neustaeter A, Lee SH, Xue M, et al
   IL23R genetic variants associate with Crohn's disease risk and microbiome changes in healthy first-degree relatives.
   Clin Gastroenterol Hepatol. 2026 May 27:S1542-3565(26)00390.
   PubMed         Abstract available
   
   
8. HANZEL J, Yuan Y, Goodwin SW, Nardone OM, et al
   Patient-reported Outcomes in Clinical Trials of Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
   Clin Gastroenterol Hepatol. 2026 May 28:S1542-3565(26)00394.
   PubMed         Abstract available
   
   

   
   Dig Dis Sci

9. SHI P, Deng J, Song X, Tang L, et al
   ABCG2 Upregulation Involving AKT/NF-kappaB Signaling Contributes to Intestinal Barrier Dysfunction in Inflammatory Bowel Disease.
   Dig Dis Sci. 2026 May 29. doi: 10.1007/s10620-026-10016.
   PubMed         Abstract available
   
   
10. YAGI S, Furukawa S, Miyake T, Yoshida O, et al
    Association Between Toothbrushing Habits and Mucosal Healing in Japanese Patients with Ulcerative Colitis.
    Dig Dis Sci. 2026 May 28. doi: 10.1007/s10620-026-09990.
    PubMed         Abstract available
    
    
11. KELLERMAYER R, Berens DP, Szigeti RG
    Dolichocolon May Differentially Associate with Ulcerative Colitis Phenotype in Children.
    Dig Dis Sci. 2026 May 25. doi: 10.1007/s10620-026-10005.
    PubMed         Abstract available
    
    
12. DEVI J, Colbert CY, Dar SH, Gros B, et al
    Healthcare Providers' Perspectives on the Role of Artificial Intelligence in the Care of Patients with Inflammatory Bowel Disease: An International Survey.
    Dig Dis Sci. 2026 May 24. doi: 10.1007/s10620-026-09987.
    PubMed         Abstract available
    
    
13. KUANG R, Levinthal DJ, Cummings C, Ramos Rivers C, et al
    Pain and IBD: The Contributing Role of Diet and Nutrition.
    Dig Dis Sci. 2026;71:1694-1704.
    PubMed         Abstract available
    
    
14. CALABRESE F, Pasta A, Formisano E, Marabotto E, et al
    Diet in Inflammatory Bowel Diseases: Efficacy, Tolerability, and Microbiome Effects Toward Personalized Management.
    Dig Dis Sci. 2026;71:1650-1676.
    PubMed         Abstract available
    
    
15. TROIA A, Harvey S, Wu A, Kiparizoska S, et al
    Understanding the Link Between Patient Symptoms and Provider Goals for Mucosal Healing in IBD: Insights from the IBD Qorus Survey.
    Dig Dis Sci. 2026;71:1738-1747.
    PubMed         Abstract available
    
    
16. CABAN M, Pikus E, Czarnecka-Chrebelska K, Oszajca K, et al
    Use of Sodium Butyrate and Its Microencapsulated Forms in Intestinal Diseases-Current Clinical Approach.
    Dig Dis Sci. 2025 Nov 14. doi: 10.1007/s10620-025-09536.
    PubMed         Abstract available
    
    

    
    Dis Colon Rectum

17. NEWLAND JJ, Grunhut J, Belcher R, Lopez KE, et al
    Trends in Colorectal Dysplasia in Patients with Inflammatory Bowel Disease.
    Dis Colon Rectum. 2026 May 25. doi: 10.1097/DCR.0000000000004289.
    PubMed         Abstract available
    
    
18. SCHMIDT MM, Kjaer S, Bulut O, Norager CB, et al
    Short-term Surgical Outcomes After Transanal Restorative Proctocolectomy With IPAA: A Comparison of Close Rectal Dissection and Modified Total Mesorectal Excision.
    Dis Colon Rectum. 2026;69:1697-1701.
    PubMed         Abstract available
    
    

    
    Eur J Gastroenterol Hepatol

19. FARAH A, Mari A
    Interpretation of surgical recurrence in the dynamic phenotype of Crohn's disease.
    Eur J Gastroenterol Hepatol. 2026;38:884.
    PubMed        
    
    
20. BINDER IMH, Brynskov J, Attauabi M
    Chest X-ray prior to biological treatment in inflammatory bowel diseases: it is not only about tuberculosis - a case report and literature review.
    Eur J Gastroenterol Hepatol. 2026;38:836-839.
    PubMed         Abstract available
    
    
21. SLEUTJES JAM, van de Pol N, van der Meer AJ, de Man RA, et al
    Cardiovascular risk profiles in patients with primary sclerosing cholangitis.
    Eur J Gastroenterol Hepatol. 2026 Feb 23. doi: 10.1097/MEG.0000000000003146.
    PubMed         Abstract available
    
    

    
    Gastroenterol Hepatol

22. QUERA R, Nunez P, Flores L
    Comment on: Vaccination recommendations and adherence in Inflammatory Bowel Disease: a physician-patient discordance study: There is still room for improvement.
    Gastroenterol Hepatol. 2026 May 21:502781. doi: 10.1016/j.gastrohep.2026.502781.
    PubMed        
    
    

    
    Gastroenterology

23. XUE M, McShane C, Kim J, Khorasaniha R, et al
    beta-Glucan and Inulin Estimated Intake Are Associated With Reduced Risk of Crohn's Disease, Improved Gut Barrier and Systemic Inflammation Markers, and Multi-Omic Signatures in a High-Risk Cohort.
    Gastroenterology. 2026 May 28:S0016-5085(26)06883.
    PubMed         Abstract available
    
    
24. BURISCH J, Marsiglio M, Keszthelyi D
    Consensus on Irritable Bowel Syndrome-like Symptoms in Inflammatory Bowel Disease: A Step Toward Advancing Patient-Centered Care.
    Gastroenterology. 2026 May 25:S0016-5085(26)06931.
    PubMed        
    
    
25. DUAN M, Zhang X, Liu W, Ke J, et al
    Mid- to Long-Term Outcomes of the MESOCOLIC Trial Evaluating Extensive Versus Limited Mesenteric Excision in Crohn's Disease.
    Gastroenterology. 2026 May 27:S0016-5085(26)06881.
    PubMed        
    
    

    
    Gut

26. CHEN R, Turpin W, Allez M, Silverberg MS, et al
    From preclinical phase of Crohn's disease to postoperative recurrence: shared mechanisms and potential interventions.
    Gut. 2026 May 28:gutjnl-2025-337981. doi: 10.1136/gutjnl-2025-337981.
    PubMed         Abstract available
    
    

    
    Inflamm Bowel Dis

27. KOCHKARIAN T, Lopez KM, Ou R, Powell DW, et al
    Matrix metalloproteinases in intestinal fibrosis and fibrostenosing Crohn's disease: Current evidence, mechanistic hypotheses, and translational challenges.
    Inflamm Bowel Dis. 2026 May 25:izag088. doi: 10.1093.
    PubMed         Abstract available
    
    
28. MACONI G, Bezzio C, Saleh A, Silva Mendes S, et al
    Transperineal contrast-enhanced ultrasound: a rapid and reliable tool for differentiating abscesses from inflammatory masses in perianal Crohn's disease.
    Inflamm Bowel Dis. 2026 May 26:izag089. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Clin Gastroenterol

29. ELDESOUKI MH, Rabea E, Aldemerdash MA, Tageldin O, et al
    Comparison of Ustekinumab and Vedolizumab Effectiveness in Perianal Crohn's Disease: A Retrospective Propensity Matched Cohort Study.
    J Clin Gastroenterol. 2026 May 28. doi: 10.1097/MCG.0000000000002398.
    PubMed         Abstract available
    
    

    
    J Crohns Colitis

30. FENG GS, Little RD, Ardalan Z, Friedman AB, et al
    The introduction of an intestinal ultrasound service is associated with significantly reduced endoscopy usage in an inflammatory bowel disease service-the SCOPELESS study.
    J Crohns Colitis. 2026;20:jjag068.
    PubMed         Abstract available
    
    
31. KHAN J, Bassi M, Daniels DK
    Mucocutaneous Crohn's disease without gastrointestinal symptoms: a case of oral lesions responsive to risankizumab.
    J Crohns Colitis. 2026;20:jjag069.
    PubMed        
    
    
32. MOTISI BERTULLI A, Bezzio C, Marsano S, Corradini I, et al
    Does inflammatory bowel disease play a role in cognitive decline? A systematic review.
    J Crohns Colitis. 2026;20:jjag057.
    PubMed         Abstract available
    
    

    
    J Gastroenterol

33. FAN X, Zhang G
    Comment on "Real-world outcomes of ustekinumab, vedolizumab, and tumor necrosis factor inhibitors in very-early-onset inflammatory bowel disease": treatment comparison or treatment sequencing?
    J Gastroenterol. 2026 May 27. doi: 10.1007/s00535-026-02451.
    PubMed        
    
    

    
    PLoS One

34. HITCHON CA, Bernstein CN, Bolton JM, Dolovich C, et al
    Impact of depression and anxiety on health-related quality of life changes over time within individuals with rheumatoid arthritis or inflammatory bowel disease: A prospective Canadian cohort study.
    PLoS One. 2026;21:e0349140.
    PubMed         Abstract available
    
    

    
    Z Gastroenterol

35. STALLMACH A, Kolleck M
    [Appendectomy as a disease-modifying therapy in ulcerative colitis?].
    Z Gastroenterol. 2026 May 29. doi: 10.1055/a-2871-3663.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum